Anaferon (pediatric formulation) reduces the incidence of acute respiratory viral infections in sickly children and children with bronchial asthma and has a positive effect on the course of asthma. The preparation produces an immunomodulating effect (increases initially low IFN-γ levels and normalizes elevated levels of IL-1β), stimulates synthesis of IgA and IgG, exhibits cytoprotective activity, and improves local immunity of the upper airways in sickly children.
Similar content being viewed by others
References
V. G. Dorofeichuk, Lab. Delo, No. 1, 28–30 (1968).
F. I. Ershov, Interferon System in Health and Disease [in Russian], Moscow (1996).
Clinical Evaluation of Laboratory Tests [in Russian], Ed. N. U. Tits, Moscow (1997).
G. F. Lakin, Biometry [in Russian], Moscow (1990).
L. A. Matveeva, Local Respiratory Tract Defense in Children [in Russian], Tomsk (1993).
T. A. Semenenko, Vestn. Ross. Akad. Med. Nauk., No. 11, 25–29 (2001).
V. F. Uchaikin, O. I. Epshtein, S. A. Sergeeva, et al., Anaferon (Pediatric Formulation), Immunocorrector Preparation with Antiviral Activity Created in Russia. Manual for Pediatricians and Infectiologists [in Russian], Moscow (2003).
G. Mancini, A. O. Garbonare, and I. F. Hаremans, Immunochemistry, No. 2, 235 (1965).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 13–17, August, 2009
Rights and permissions
About this article
Cite this article
Kondrat’eva, E.I., Matveeva, L.A., Shemyakina, T.A. et al. The Use of Anaferon (Pediatric Formulation) for Prophylaxis of Acute Respiratory Viral Infections in Preschool Children. Bull Exp Biol Med 148, 266–269 (2009). https://doi.org/10.1007/s10517-009-0704-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-009-0704-y